e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Advances in the future treatment of severe asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED
Christos Rossios (London, United Kingdom), Christos Rossios, Matt Loza, Stelios Pavlidis, Antony Rowe, Ratko Djukanovic, Fred Baribaud, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, On Behalf of U-BIOPRED Study Group
Source:
International Congress 2015 – Advances in the future treatment of severe asthma
Session:
Advances in the future treatment of severe asthma
Session type:
Oral Presentation
Number:
1773
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christos Rossios (London, United Kingdom), Christos Rossios, Matt Loza, Stelios Pavlidis, Antony Rowe, Ratko Djukanovic, Fred Baribaud, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, On Behalf of U-BIOPRED Study Group. Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED. Eur Respir J 2015; 46: Suppl. 59, 1773
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Multi-analyte profiling of inflammatory markers in COPD sputum
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Altered circulating exosomal RNA profiles detected by next-generation sequencing in patients with severe asthma
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
The first U-BIOPRED sputum handprint of severe asthma
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Differential macrophage activation in asthmatic sputum using U-BIOPRED transcriptomics
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept